Non-linear relationship between anti-apolipoprotein A-1 IgGs and cardiovascular outcomes in patients with acute coronary syndromes
N Vuilleumier, S Pagano, C Combescure… - Journal of clinical …, 2019 - mdpi.com
Autoantibodies against apolipoprotein AI (anti-apoA-I IgGs) are prevalent in atherosclerosis-
related conditions. It remains elusive whether they improve the prognostic accuracy of the …
related conditions. It remains elusive whether they improve the prognostic accuracy of the …
Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome
N Vuilleumier, E Charbonney, L Fontao… - Clinical …, 2008 - portlandpress.com
ApoA-1 (apolipoprotein A-1) is the main component of HDL (high-density lipoprotein) and
stabilizes PON-1 (paraoxonase-1), which prevents lipid peroxidation and oxLDL (oxidized …
stabilizes PON-1 (paraoxonase-1), which prevents lipid peroxidation and oxLDL (oxidized …
Prognostic and therapeutic considerations of antibodies against c‐ter apolipoprotein A‐1 in the general population
N Vuilleumier, P Antiochos… - Clinical & …, 2020 - Wiley Online Library
Objectives Autoantibodies against apolipoprotein A1 (anti‐apoA1 IgGs) and its C‐terminal
region (cter apoA1) have emerged as an independent biomarker for cardiovascular disease …
region (cter apoA1) have emerged as an independent biomarker for cardiovascular disease …
Diagnostic and prognostic value of autoantibodies anti‐apolipoprotein A‐1 and anti‐phosphorylcholine in acute non‐ST elevation myocardial infarction
M Rubini Gimenez, S Pagano, J Virzi… - European journal of …, 2015 - Wiley Online Library
Background Autoantibodies have been shown to play a critical role in predicting major
adverse cardiovascular events in atherosclerotic patients. We aimed to assess the …
adverse cardiovascular events in atherosclerotic patients. We aimed to assess the …
Association Between ApoA-I (Apolipoprotein AI) Immune Complexes and Adverse Cardiovascular Events—Brief Report
D Henson, AS Tahhan, D Nardo, AA Quyyumi… - 2019 - Am Heart Assoc
Objective: The immune response is linked to the progression of atherosclerotic
cardiovascular disease (CVD). Free autoantibodies targeting ApoA-I (apolipoprotein AI) …
cardiovascular disease (CVD). Free autoantibodies targeting ApoA-I (apolipoprotein AI) …
Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability
F Montecucco, N Vuilleumier, S Pagano… - European heart …, 2011 - academic.oup.com
Abstract Aims Anti-Apolipoprotein A-1 auto-antibodies (anti-ApoA-1 IgG) represent an
emerging prognostic cardiovascular marker in patients with myocardial infarction or …
emerging prognostic cardiovascular marker in patients with myocardial infarction or …
Association between anti-apolipoprotein A-1 antibodies and cardiovascular disease in the general population
P Antiochos, P Marques-Vidal, J Virzi… - Thrombosis and …, 2016 - thieme-connect.com
We aimed to determine the association between autoantibodies against apolipoprotein A-1
(anti-apoA-1 IgG) and prevalent cardiovascular (CV) disease (CVD) as well as markers of …
(anti-apoA-1 IgG) and prevalent cardiovascular (CV) disease (CVD) as well as markers of …
Associations between circulating IgG antibodies to Apolipoprotein B100-derived peptide antigens and acute coronary syndrome in a Chinese Han population
Objectives: Acute coronary syndrome (ACS) is the major cause of mortality worldwide and
caused mainly by atherosclerosis of coronary arteries. Apolipoprotein B100 (ApoB100) is a …
caused mainly by atherosclerosis of coronary arteries. Apolipoprotein B100 (ApoB100) is a …
Anti-apolipoprotein A-1 autoantibodies as risk biomarker for cardiovascular diseases in type 2 diabetes mellitus
D El-Lebedy, E Rasheed, M Kafoury… - Journal of Diabetes and …, 2016 - Elsevier
Abstract Objective Anti-Apolipoprotein A-1 autoantibodies (anti-ApoA-1 IgG) represent an
emerging prognostic cardiovascular marker in patients with myocardial infarction or …
emerging prognostic cardiovascular marker in patients with myocardial infarction or …
[HTML][HTML] Autoantibodies to apolipoprotein A-1 as a biomarker of cardiovascular autoimmunity
N Vuilleumier, F Montecucco… - World journal of …, 2014 - ncbi.nlm.nih.gov
Immune-driven inflammation plays an important part in atherogenesis and is therefore
believed to be key to the development of cardiovascular disease (CVD), which is currently …
believed to be key to the development of cardiovascular disease (CVD), which is currently …